Corticosteroids for the treatment of Kawasaki disease in children

Andrew J. Wardle*, Harriet C. Kiddy, Matthew J. Seager, Robert M.R. Tulloh, Michael Levin

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

95 Citations (Scopus)


This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the role of corticosteroids for a reduction in the incidence of coronary aneurysms in Kawasaki disease (KD), as either first-line or second-line treatment. Corticosteroids may be given alone or in conjunction with other accepted KD treatments. Secondary objectives will include to determine the effects of steroids on mortality, biochemical parameters and duration of acute symptoms including fever as well as evaluating their safety in KD and efficacy in relevant population subgroups.

Original languageEnglish
Article numberCD011188
JournalCochrane Database of Systematic Reviews
Issue number8
Publication statusPublished - 4 Aug 2014


Dive into the research topics of 'Corticosteroids for the treatment of Kawasaki disease in children'. Together they form a unique fingerprint.

Cite this